SK9492000A3 - Pharmaceutical composition containing sibutramine and orlistat - Google Patents

Pharmaceutical composition containing sibutramine and orlistat Download PDF

Info

Publication number: SK9492000A3
Authority: SK; Slovakia
Prior art keywords: formula; compound; orlistat; compounds; treatment
Prior art date: 1997-12-24

Application number

SK949-2000A

Other languages

English (en)

Slovak (sk)

Inventor

David John Heal

Helen Christine Jackson

Original Assignee

Knoll Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-12-24

Filing date

1998-12-16

Publication date

2001-07-10

1998-12-16 Application filed by Knoll Ag filed Critical Knoll Ag

2001-07-10 Publication of SK9492000A3 publication Critical patent/SK9492000A3/sk

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Obesity (AREA)
Hematology (AREA)
Diabetes (AREA)
Cardiology (AREA)
Hospice & Palliative Care (AREA)
Heart & Thoracic Surgery (AREA)
Child & Adolescent Psychology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)

SK949-2000A 1997-12-24 1998-12-16 Pharmaceutical composition containing sibutramine and orlistat SK9492000A3 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9727131.6A GB9727131D0 (en)	1997-12-24	1997-12-24	Therapeutic agents
PCT/EP1998/008249 WO1999033450A2 (fr)	1997-12-24	1998-12-16	Agents therapeutiques

Publications (1)

Publication Number	Publication Date
SK9492000A3 true SK9492000A3 (en)	2001-07-10

Family

ID=10824083

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SK949-2000A SK9492000A3 (en)	1997-12-24	1998-12-16	Pharmaceutical composition containing sibutramine and orlistat

Country Status (26)

Country	Link
US (1)	US6403641B2 (fr)
EP (1)	EP1039900B1 (fr)
JP (1)	JP2001527036A (fr)
KR (1)	KR20010033531A (fr)
CN (1)	CN1134257C (fr)
AT (1)	ATE268174T1 (fr)
AU (1)	AU758181B2 (fr)
BG (1)	BG104568A (fr)
BR (1)	BR9814498A (fr)
CA (1)	CA2315259A1 (fr)
CZ (1)	CZ20002392A3 (fr)
DE (1)	DE69824313T2 (fr)
DK (1)	DK1039900T3 (fr)
ES (1)	ES2222001T3 (fr)
GB (1)	GB9727131D0 (fr)
HK (1)	HK1034446A1 (fr)
HU (1)	HUP0300615A3 (fr)
IL (1)	IL136733A (fr)
NO (1)	NO20003313L (fr)
NZ (1)	NZ505686A (fr)
PL (1)	PL342099A1 (fr)
PT (1)	PT1039900E (fr)
SK (1)	SK9492000A3 (fr)
TR (1)	TR200001869T2 (fr)
UA (1)	UA70310C2 (fr)
WO (1)	WO1999033450A2 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6339106B1 (en)	1999-08-11	2002-01-15	Sepracor, Inc.	Methods and compositions for the treatment and prevention of sexual dysfunction
US6476078B2 (en)	1999-08-11	2002-11-05	Sepracor, Inc.	Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction
US6974838B2 (en)	1998-08-24	2005-12-13	Sepracor Inc.	Methods of treating or preventing pain using sibutramine metabolites
US6331571B1 (en)	1998-08-24	2001-12-18	Sepracor, Inc.	Methods of treating and preventing attention deficit disorders
GB9914744D0 (en) *	1999-06-24	1999-08-25	Knoll Ag	Therapeutic agents
US6399826B1 (en)	1999-08-11	2002-06-04	Sepracor Inc.	Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain
DE60106623T2 (de)	2000-07-28	2006-02-02	F. Hoffmann-La Roche Ag	Neue pharmazeutische zusammensetzung
US6610887B2 (en)	2001-04-13	2003-08-26	Sepracor Inc.	Methods of preparing didesmethylsibutramine and other sibutramine derivatives
US6730319B2 (en)	2001-06-06	2004-05-04	Hoffmann-La Roche Inc.	Pharmaceutical compositions having depressed melting points
US20060166957A1 (en) *	2003-06-12	2006-07-27	Menachem Rubinstein	Methods of treating obesity and related disorders using tellurium selenium compounds
US20050131074A1 (en) *	2003-08-04	2005-06-16	Beckman Kristen M.	Methods for treating metabolic syndrome
EP1744772B1 (fr)	2004-05-10	2017-08-16	University of Copenhagen	Graines de lin permettant de gerer le poids du corps
EP2625968A1 (fr)	2007-09-12	2013-08-14	Københavns Universitet	Compositions et procédés pour mieux supprimer la sensation de faim et réduire la digestibilité d'une énergie non grasse et prolonger l'effet de satiété
US20090214682A1 (en) *	2008-02-22	2009-08-27	Heuer Marvin A	Composition and methods for weight loss in a subject
JP5738011B2 (ja) *	2011-03-04	2015-06-17	株式会社ブリヂストン	二次電池の非水電解液用添加剤、二次電池用非水電解液及び非水電解液二次電池
CN102872062A (zh) *	2011-07-13	2013-01-16	鲁南制药集团股份有限公司	一种治疗或预防肥胖症以及代谢综合症的药物组合物
JP2013147488A (ja) *	2011-12-21	2013-08-01	Taisho Pharmaceutical Co Ltd	固形製剤

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IE52768B1 (en)	1981-04-06	1988-02-17	Boots Co Ltd	1-arylcyclobutylalkylamine compounds useful as therapeutic agents
CA1247547A (fr) *	1983-06-22	1988-12-28	Paul Hadvary	Derives de leucine
CA1328881C (fr)	1984-12-21	1994-04-26	Pierre Barbier	Procede pour la fabrication d'oxetanones
GB8531071D0 (en)	1985-12-17	1986-01-29	Boots Co Plc	Therapeutic compound
GB8704777D0 (en)	1987-02-28	1987-04-01	Boots Co Plc	Medical treatment
JP2675573B2 (ja)	1988-03-31	1997-11-12	科研製薬株式会社	脳機能改善剤
IE61928B1 (en)	1988-11-29	1994-11-30	Boots Co Plc	Treatment of obesity
CA2128044C (fr)	1993-08-05	2007-02-20	Klaus-Dieter Bremer	Compositions pharmaceutiques comportant un glucosidase et/ou un inhibiteur d'amylase, et un inhibiteur des lipases
US5459164A (en)	1994-02-03	1995-10-17	Boots Pharmaceuticals, Inc.	Medical treatment

1997
- 1997-12-24 GB GBGB9727131.6A patent/GB9727131D0/en not_active Ceased
1998
- 1998-12-16 CZ CZ20002392A patent/CZ20002392A3/cs unknown
- 1998-12-16 IL IL13673398A patent/IL136733A/en not_active IP Right Cessation
- 1998-12-16 PT PT98966345T patent/PT1039900E/pt unknown
- 1998-12-16 PL PL98342099A patent/PL342099A1/xx unknown
- 1998-12-16 JP JP2000526207A patent/JP2001527036A/ja active Pending
- 1998-12-16 BR BR9814498-7A patent/BR9814498A/pt not_active IP Right Cessation
- 1998-12-16 SK SK949-2000A patent/SK9492000A3/sk unknown
- 1998-12-16 HU HU0300615A patent/HUP0300615A3/hu unknown
- 1998-12-16 WO PCT/EP1998/008249 patent/WO1999033450A2/fr not_active Application Discontinuation
- 1998-12-16 TR TR2000/01869T patent/TR200001869T2/xx unknown
- 1998-12-16 EP EP98966345A patent/EP1039900B1/fr not_active Expired - Lifetime
- 1998-12-16 AT AT98966345T patent/ATE268174T1/de not_active IP Right Cessation
- 1998-12-16 CA CA002315259A patent/CA2315259A1/fr not_active Abandoned
- 1998-12-16 ES ES98966345T patent/ES2222001T3/es not_active Expired - Lifetime
- 1998-12-16 CN CNB988137399A patent/CN1134257C/zh not_active Expired - Fee Related
- 1998-12-16 DE DE69824313T patent/DE69824313T2/de not_active Expired - Fee Related
- 1998-12-16 DK DK98966345T patent/DK1039900T3/da active
- 1998-12-16 AU AU22738/99A patent/AU758181B2/en not_active Ceased
- 1998-12-16 KR KR1020007007034A patent/KR20010033531A/ko not_active Ceased
- 1998-12-16 UA UA2000074417A patent/UA70310C2/uk unknown
- 1998-12-16 NZ NZ505686A patent/NZ505686A/en unknown
- 1998-12-16 US US09/212,249 patent/US6403641B2/en not_active Expired - Fee Related
2000
- 2000-06-23 NO NO20003313A patent/NO20003313L/no not_active Application Discontinuation
- 2000-06-28 BG BG104568A patent/BG104568A/bg unknown
2001
- 2001-07-13 HK HK01104909A patent/HK1034446A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
DK1039900T3 (da)	2004-10-04
BR9814498A (pt)	2000-10-10
HK1034446A1 (en)	2001-10-26
WO1999033450A3 (fr)	1999-09-02
NO20003313L (no)	2000-08-11
UA70310C2 (uk)	2004-10-15
PT1039900E (pt)	2004-09-30
DE69824313D1 (de)	2004-07-08
GB9727131D0 (en)	1998-02-25
AU2273899A (en)	1999-07-19
AU758181B2 (en)	2003-03-20
EP1039900A2 (fr)	2000-10-04
KR20010033531A (ko)	2001-04-25
NO20003313D0 (no)	2000-06-23
NZ505686A (en)	2002-07-26
CN1284872A (zh)	2001-02-21
IL136733A (en)	2004-08-31
ES2222001T3 (es)	2005-01-16
HUP0300615A3 (en)	2005-04-28
PL342099A1 (en)	2001-05-21
ATE268174T1 (de)	2004-06-15
CZ20002392A3 (cs)	2002-01-16
IL136733A0 (en)	2001-06-14
CN1134257C (zh)	2004-01-14
TR200001869T2 (tr)	2000-10-23
WO1999033450A2 (fr)	1999-07-08
BG104568A (bg)	2001-02-28
DE69824313T2 (de)	2005-08-25
EP1039900B1 (fr)	2004-06-02
US20020010160A1 (en)	2002-01-24
JP2001527036A (ja)	2001-12-25
HUP0300615A2 (hu)	2003-07-28
CA2315259A1 (fr)	1999-07-08
US6403641B2 (en)	2002-06-11

Publication	Publication Date	Title
US6365633B1 (en)	2002-04-02	Method of treating eating disorders
US20030130355A1 (en)	2003-07-10	Therapeutic agents
EP1039900B1 (fr)	2004-06-02	Agents therapeutiques contenant sibutramine et orlistat
US6376552B1 (en)	2002-04-23	Treatment of gallstones
US6355685B1 (en)	2002-03-12	Method of treating anxiety disorders
RU2229289C2 (ru)	2004-05-27	Фармацевтическая композиция, содержащая сибутрамин и орлистат
US6441046B1 (en)	2002-08-27	Control of metabolism
SK18822001A3 (sk)	2003-04-01	Terapeutické činidlá
US6232347B1 (en)	2001-05-15	Treatment of osteoarthritis
AU773490B2 (en)	2004-05-27	Treatment of osteoarthritis
US6803387B1 (en)	2004-10-12	Treatment of neuropathic pain or fibromyalgia
US6403650B1 (en)	2002-06-11	Treatment of pulmonary hypertension
US6365632B1 (en)	2002-04-02	Treatment of orthostatic hypotension
US6288125B1 (en)	2001-09-11	Treatment of hiatial hernia
US20030008897A1 (en)	2003-01-09	Method of controlling weight gain associated with therapeutic drugs
RU2234917C2 (ru)	2004-08-27	Терапевтические средства
US20030013735A1 (en)	2003-01-16	Weight loss after pregnancy
EP1162966A1 (fr)	2001-12-19	Perte de poids apres une grossesse